ArisGlobal

Reflections on the last year It’s hard to believe that I’ve now completed my first year at ArisGlobal . It’s been a whirlwind year of learning, new experiences, travel, and building strong connections across both the company and the wider pharma industry. After spending much of my career at Roche , moving into the technology partner side of the industry has broadened my perspective enormously. Experiencing both pharma and vendor environments has given me a deeper appreciation of the challenges, opportunities, and expectations on all sides — and the importance of building true partnerships focused on delivering meaningful outcomes for patients. Over the past year, I’ve had the privilege of leading the development of the vision and strategy for ArisGlobal’s pharmacovigilance product suite at a particularly exciting point in the industry’s evolution. Bringing together experience from within pharma alongside a growing understanding of the technology and product landscape has allowed me to contribute a perspective that bridges customer needs, operational realities, regulatory requirements, and innovation opportunities. One aspect of the role I’ve particularly valued is being a strong advocate for the customer perspective within our organisation — helping ensure that the solutions we design are grounded not only in innovation, but also in the real-world challenges faced by both pharma companies and regulators using our products. Working with customers across the industry, including regulatory agencies, has given me an even greater appreciation of the importance of usability, trust, and delivering technology that genuinely advances critical safety processes. I’ve also been very lucky to work with such a talented and supportive Safety Product Team, alongside strong partners across the business whose collaboration and shared focus on customer outcomes has made the last year both enjoyable and hugely rewarding. Within the Safety Product Team, I’ve been continually impressed by the depth of PV expertise, openness to challenge and new ideas, and relentless focus on delivering real value for customers. More broadly across ArisGlobal, the pace of execution, quality of thinking, and commitment to driving meaningful progress across the industry has been genuinely impressive. What excites me most for the year ahead is continuing to lead the strategy and evolution of solutions that help organisations move towards more proactive pharmacovigilance — including the application of emerging agentic AI capabilities — while keeping patient safety, customer value, and practical real-world impact firmly at the centre of everything we do. I’m excited for what we’ll continue to achieve together over the next year. #SafetyProductManagementTeam #Pharmacovigilance #AI #PatientSafety

Honored to receive the #Values #Champion #Award for leading the strategic launch of #Signals #Agents at #Breakthrough #2026. #Signals #Agents represents an important step toward operationalizing AI in #Signal #Management — enabling smarter signal detection, faster insights, intelligent prioritization, and more connected safety workflows. #Proud to contribute to building trusted, explainable, and scalable AI capabilities that can truly transform how safety teams work and make decisions. A big thank you to the #leadership and teams at ArisGlobal for the trust, collaboration, and shared vision to shape the future of AI-powered Safety Science. Excited for what’s ahead. #AI #AgenticAI #SignalsAgents #Pharmacovigilance #DrugSafety #SignalManagement #SafetyScience #Innovation #LifeSciences #ArisGlobal

What a day in Tokyo! We officially kicked off the #BTAPAC26 and there is a noticeable shift in the room. Not just bigger in scale, but sharper in intent. You could feel that we’re moving from ideas to something far more tangible. ArisGlobal #BTAPAC26 #LifeSphere #NavaX